ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
twitter youtube facebook linkedin iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • ATTENDEE MAP & PHOTOS
  • Register Now
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • ATTENDEE MAP & PHOTOS
  • Register Now
loading...
Home Archives for August 2021

Narjust Duma Moves to Dana-Farber Cancer Institute

on: August 28, 2021In: Names & News
Narjust Duma Moves to Dana-Farber Cancer Institute

Narjust Duma, MD, has been named associate director of the Cancer Care Equity Program and assistant professor of medicine at Dana-Farber Cancer Institute/Harvard Medical School. She will develop strategies to […] Read more

Gemcitabine: A New Chemotherapy Partner for Immune Checkpoint Inhibitors? Insights From the ORIENT-12 Study

Chunxia Su
on: August 27, 2021In: Evolving Standards of Care
Gemcitabine: A New Chemotherapy Partner for Immune Checkpoint Inhibitors? Insights From the ORIENT-12
            Study

Squamous cell lung cancer (SqCLC), which accounts for approximately 25% to 30% of all lung cancer cases, is the second-most prevalent histologic subtype of NSCLC. Its distinct clinicopathologic and molecular […] Read more

Peter Bach, MD, is the New Chief Medical Officer at Delfi Diagnostic

on: August 27, 2021In: Names & News
Peter Bach, MD, is the New Chief Medical Officer at Delfi Diagnostic

Peter Bach, MD, is the new chief medical officer at Delfi Diagnostics, a developer of blood tests for early detection of multiple types of cancer. Dr. Bach leaves Memorial Sloan […] Read more

Joshua Bauml, MD, moves to The Janssen Pharmaceutical Companies of Johnson & Johnson

on: August 27, 2021In: Names & News
Joshua Bauml, MD, moves to The Janssen Pharmaceutical Companies of Johnson & Johnson

Joshua Bauml, MD, has moved to The Janssen Pharmaceutical Companies of Johnson & Johnson from the University of Pennsylvania. Dr. Bauml was with the University of Pennsylvania for a decade—2 […] Read more

Jean-Charles Soria, MD, PhD Joins Amgen

on: August 27, 2021In: Names & News
Jean-Charles Soria, MD, PhD Joins Amgen

Jean-Charles Soria, MD, PhD, joined Amgen in early August 2021 as senior vice president of the oncology therapeutic sector. Prof. Soria, previously served as senior vice president of Research & […] Read more


Suresh S. Ramalingam, MD, Appointed Executive Director of the Winship Cancer Institute and Associate Vice-President for Cancer at the Woodruff Health Sciences Center of Emory University

on: August 27, 2021In: Names & News
Suresh S. Ramalingam, MD, Appointed Executive Director of the Winship Cancer Institute and Associate
            Vice-President for Cancer at the Woodruff Health Sciences Center of Emory University

Suresh S. Ramalingam, MD, was appointed as the executive director of the Winship Cancer Institute and Associate Vice-President for Cancer at the Woodruff Health Sciences Center of Emory University on […] Read more

Telehealth Struggles to Find Permanent Footing After Rapid Growth During Pandemic

Beth Fand Incollingo
on: August 27, 2021In: Evolving Standards of Care
Telehealth Struggles to Find Permanent Footing After Rapid Growth During Pandemic

The ILCN is aware that the situation with telehealth differs across regions and that lack of access to technology is a huge obstacle. We would love to hear from IASLC members around the globe about your experiences. Please email us at [email protected] Read more

Therapeutic Vaccine Development in Lung Cancer: Update and Recent Advances

Mohamad Omar Ashi
+more
on: August 27, 2021In: Evolving Standards of Care
Therapeutic Vaccine Development in Lung Cancer: Update and Recent Advances

Most cancer immunotherapies currently in development aim to stimulate antitumor T-cell responses either by adoptive transfer of in vitro expanded native or genetically modified T lymphocytes targeting malignant cells,1 ,2 […] Read more


Radiotherapy Inaccessibility in Lung Cancer Care: An Ongoing Crisis

Federico Maldonado Magos
+more
on: August 27, 2021In: Radiation Oncology
Radiotherapy Inaccessibility in Lung Cancer Care: An Ongoing Crisis

A leading cause of mortality worldwide, cancer was tied to nearly 10 million deaths in 2020.1 Lung cancer has remained unchallenged for more than 30 years as the most commonly […] Read more

Economics of Locally Advanced Lung Cancer Before and During COVID-19 Pandemic: A Perspective for Developing Countries

Andrés F. Cardona
+more
on: August 13, 2021In: Evolving Standards of Care
Economics of Locally Advanced Lung Cancer Before and During COVID-19 Pandemic: A Perspective for
            Developing Countries

Since December 2019, the world has been mired in a pandemic that has displaced other 21st-century health priorities for many populations. The social significance and speed of contagion from COVID-19 […] Read more

12

Follow IASLC on Twitter

Tweets by @IASLC

IASLC Logo
ILCN Editorial Group   IASLC.org

© 2022 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC

Privacy Policy